Additionally, we observed that expression of chemerin receptor CCRL2 was elevated in the neuroblastoma cohorts compared to neurofibroma and neural crest, and that high expression of CCRL2 correlated with a poor survival prognosis (Supplementary Figure 1D-1F). Here, CCRL2 is linked to neuroblastoma.